Mortality risk is dose-dependent on the number of packed red blood cell transfused after coronary artery bypass graft;Risco de mortalidade é dose-dependente do número de unidades de concentrado de hemácias transfundidas após cirurgia de revascularização miocárdica

Brazilian Journal of Cardiovascular Surgery

Volumn 28, Issue 4, 2013, Pages 509-517

  Santos, Antônio Alceu dos ^a,b,c   Sousa, Alexandre Gonçalves ^a   Piotto, Raquel Ferrari ^a   Pedroso, Juan Carlos Montano ^d  

^a Hosp da Real Benemerita S   (Brazil)

^b Instituto Vis Research   (Brazil)

^c Sociedade Brasileira de Cardiologia   (Brazil)

^d Sociedade Brasileira de Cirurgia Plástica Brasilian Society of Plastic Surgery   (Brazil)

Author keywords

Blood transfusion; Mortality; Myocardial revascularization; Postoperative complications

Indexed keywords

ADULT; AGED; ARTICLE; CORONARY ARTERY BYPASS GRAFT; ERYTHROCYTE TRANSFUSION; FEMALE; HUMAN; MALE; MIDDLE AGED; MORTALITY; POSTOPERATIVE COMPLICATION; PROGNOSIS; PROSPECTIVE STUDY; REFERENCE VALUE; RISK; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; STATISTICS; TIME; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CORONARY ARTERY BYPASS; ERYTHROCYTE TRANSFUSION; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROSPECTIVE STUDIES; REFERENCE VALUES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84897747318     PISSN: 01027638     EISSN: 16789741     Source Type: Journal    
DOI: 10.5935/1678-9741.20130083     Document Type: Article

References (29)

1. Whitlock R, Crowther MA, Ng HJ. Bleeding in cardiac surgery: its prevention and treatment: an evidence-based review. Crit Care Clin. 2005;21(3):589-610.
2. Bennett-Guerrero E, Zhao Y, O'Brien SM, Ferguson TB Jr, Peterson ED, Gammie JS, et al. Variation in use of blood transfusion in coronary artery bypass graft surgery. JAMA. 2010;304(14):1568-75.
3. Sojka BN, Sojka P. The blood donation experience: selfreported motives and obstacles for donating blood. Vox Sang. 2008;94(1):56-63.
4. Novaretti MCZ. Importância dos carreadores de oxigênio livre de células. Rev Bras Hematol Hemoterapia. 2007;29(4):394-405.
5. Dorneles CC, Bodanese LC, Guaragna JCVC, Macagnan FE, Coelho JC, Borges AP, et al. O impacto da hemotransfusão na morbimortalidade pós-operatória de cirurgias cardíacas. Rev Bras Cir Cardiovasc. 2011;26(2):222-9.
6. Koch CG, Li L, Duncan AI, Mihaljevic T, Cosgrove DM, Loop FD, et al. Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. Crit Care Med. 2006;34(6):1608-16.
7. Vamvakas EC, Blajchman MA. Transfusion-related immunomodulation (TRIM): an update. Blood Rev. 2007;21(6):327-48.
8. Engoren MC, Habib RH, Zacharias A, Schwann TA, Riordan CJ, Durham SJ. Effect of blood transfusion on long-term survival after cardiac operation. Ann Thorac Surg. 2002;74:1180-6.
9. Santos AA, Sousa AG, Thomé HO, Machado RL, Piotto RF. Impact on early and late mortality after blood transfusion in coronary artery bypass grafting surgery. Rev Bras Cir Cardiovasc. 2013;28(1):1-9.
10. Karkouti K, Yau TM, Rensburg AV, McCluskey SA, Callum J, Wijeysundera DN, et al. The effects of a treatment protocol for cardiac surgical patients with excessive blood loss on clinical outcomes. Vox Sang. 2006;91(2):148-56.
11. Hajjar LA, Vincent JL, Galas FR, Nakamura RE, Silva CM, Santos MH, et al. Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA. 2010;304(14):1559-67.
12. Senay S, Toraman F, Karabulut H, Alhan C. Is it the patient or the physician who cannot tolerate anemia? A prospective analysis in 1854 non-transfused coronary artery surgery patients. Perfusion. 2009;24(6):373-80.
13. Bernard AC, Davenport DL, Chang PK, Vaughan TB, Zwischenberger JB. Intraoperative transfusion of 1 U to 2 U packed red blood cells is associated with increased 30-day mortality, surgical-site infection, pneumonia, and sepsis in general surgery patient. J Am Coll Surg. 2009;208(5):931-7.
14. Ferraris VA, Davenport DL, Saha SP, Austin PC, Zwischenberger JB. Surgical outcomes and transfusion of minimal amounts of blood in the operating room. Arch Surg. 2012;147(1):49-55.
15. Stone GW, Clayton TC, Mehran R, Dangas G, Parise H, Fahy M, et al. Impact of major bleeding and blood transfusions after cardiac surgery: analysis from the Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial. Am Heart J. 2012;163(3):522-9.
16. Hosmer Jr DW, Lemeshow S. Applied logistic regression. Hoboken:John Wiley & Sons; 1989. 307p.
17. Takei T, Amin NA, Schmid G, Dhingra-Kumar N, Rugg D. Progress in global blood safety for HIV. J Acquir Immune Defic Syndr. 2009;52(Suppl 2):S127-31.
18. Lundy JS. Clinical anesthesia: a manual of clinical anesthesiology. Philadelphia: WB Saunders; 1942.
19. DeFoe GR, Ross CS, Olmstead EM, Surgenor SD, Fillinger MP, Groom RC, et al. Lowest hematocrit on bypass and adverse outcomes associated with coronary artery bypass grafting. Northern New England Cardiovascular Disease Study Group. Ann Thorac Surg. 2001;71(3):769-76.
20. Sá MP, Soares EF, Santos CA, Figueiredo OJ, Lima RO, Rueda FG, et al. Predictors of transfusion of packed red blood cells in coronary artery bypass grafting surgery. Rev Bras Cir Cardiovasc. 2011;26(4):552-8.
21. Hill AB. The environment and disease: association or causation? Proc R Soc Med. 1965;58:295-300.
22. Reynolds JD, Ahearn GS, Angelo M, Zhang J, Cobb F, Stamler JS. S-nitrosohemoglobin deficiency: a mechanism for loss of physiological activity in banked blood. Proc Natl Acad Sci U S A. 2007;104(43):17058-62.
23. Flohé S, Kobbe P, Nast-Kolb D. Immunological reactions secondary to blood transfusion. Injury. 2007;38(12):1405-8.
24. Souza DD, Braile DM. Avaliação de nova técnica de hemoconcentração e da necessidade de transfusão de hemoderivados em pacientes submetidos à cirurgia cardíaca com circulação extracorpórea. Rev Bras Cir Cardiovasc. 2004;19(3):287-94.
25. Benfatti RA, Carli AF, Silva GVR, Dias AEMAS, Goldiano JA, Pontes JCDV. Influência do ácido épsilon aminocapróico no sangramento e na hemotransfusão pós-operatória em cirurgia valvar mitral. Rev Bras Cir Cardiovasc. 2010;25(4):510-5.
26. Souza HJB, Moitinho RF. Estratégias para redução do uso de hemoderivados em cirurgia cardiovascular. Rev Bras Cir Cardiovasc. 2008;23(1):53-9.
27. Lima R, Diniz R, Césio A, Vasconcelos F, Gesteira M, Menezes A, et al. Revascularização miocárdica em pacientes octogenários: estudo retrospectivo e comparativo entre pacientes operados com e sem circulação extracorpórea. Rev Bras Cir Cardiovasc. 2005;20(1):8-13.
28. Santos AA, Silva JP, Fonseca L, Baumgratz JF. Retransplante cardíaco em criança sem o uso de hemoderivados. Rev Bras Cir Cardiovasc. 2012;27(2):327-30.
29. Kumar A. Perioperative management of anemia: limits of blood transfusion and alternatives to it. Cleve Clin J Med. 2009;76(Suppl 4): S112-8.